Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| DM1-BLY73 | Mouse | Biotinylated Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (MALS verified) |
|
|
|
| DM1-PLY73 | Mouse | HRP conjugated Monoclonal Anti-DM-1&DM-4 Antibody,Mouse IgG1 |
|
|
|
| DM1-Y73 | Mouse | Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (MALS verified) |
|
|
Immobilized Trastuzumab-DM1 (T-DM1) at 2 μg/mL (100 μL/well) can bind HRP conjugated Monoclonal Anti-DM-1&DM-4 Antibody,Mouse IgG1 (Cat. No. DM1-PLY73) with a linear range of 0.24-15.63 ng/mL (QC tested).
The purity of Biotinylated Monoclonal Anti-DM-1&DM-4 Antibody, Mouse IgG1 (Cat. No. DM1-BLY73) is more than 90% and the molecular weight of this protein is around 140-160 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Delpacibart eteddesiran | AOC-1001; AOC 1001 | Phase 3 Clinical | Avidity Biosciences Inc | Myotonic Disorders; Genetic Diseases, Inborn; Musculoskeletal Diseases; Muscular Disorders, Atrophic; Myotonic Dystrophy; Muscular Atrophy; Heredodegenerative Disorders, Nervous System; Muscular Diseases; Neuromuscular Diseases; Nervous System Diseases; Muscular Dystrophies; Neurodegenerative Diseases; Myotonia | Details |
| Dyne-101 | Dyne101 | Phase 2 Clinical | Dyne Therapeutics Inc | Myotonic Dystrophy | Details |
| ARO-DM1 | ARO-DM1 | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc | Myotonic Dystrophy | Details |
This web search service is supported by Google Inc.
A-Z
